Lars H. Genieser

Lars H. Genieser, Ph.D., is a patent attorney with a practice focused predominantly on the pharmaceutical, chemical, and material sciences industries. His technical expertise spans a wide range, including oncologic drugs, antibodies, vaccines, various pharmaceutical formulations, epigenetics, nanotechnology, organometallic chemistry, quantum dots, bioinformatics, pesticides, novel polymers, coatings, and chemical and materials processes for pharmaceutical and industrial manufacturing. While his authoritative tracked cases show one defendant-side appearance, his broader practice descriptions emphasize patent prosecution and counseling, including developing and managing extensive patent portfolios for technology-driven clients.

In his tracked litigation appearance, Dr. Genieser served as Of Counsel for the defendant in Greenthread, LLC v. Intel Corporation et al. at Norton Rose Fulbright US. Beyond litigation, he has demonstrated experience in securing patent protection and managing complex international patent portfolios, such as for a successful cancer treatment drug. His professional history includes roles as a Shareholder at Nixon & Vanderhye and previously as a Partner at Panitch Schwarze Belisario & Nadel LLP. A FindLaw profile also lists an affiliation with Venable.

Dr. Genieser possesses experience in various post-grant proceedings, including successfully appealing patent application examinations to the USPTO Patent Trial and Appeal Board (PTAB) and prevailing in foreign post-grant patent oppositions. His academic credentials include a Ph.D. in Chemical Engineering from the Massachusetts Institute of Technology (1997) and a B.S. in Chemical Engineering, summa cum laude, from Princeton University (1989). He earned his J.D. from Georgetown University Law Center in 2006 and is a Registered Patent Attorney.